Latest news
AstraZeneca Pharma Gets CDSCO Nod To Sell Enhertu For Breast Cancer - NDTV ProfitNDTV Profit · Sat, 08 Aug 2026 09:00:27 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer HealthCancer Health · Mon, 03 Aug 2026 13:01:12 GMTTwo breast cancer therapies, Enhertu and Etcamah, advance through EU regulatory process - Oncology CentralOncology Central · Wed, 29 Jul 2026 10:51:53 GMTThree Cancer Drugs Advance Toward Broader EU Use - MedscapeMedscape · Tue, 28 Jul 2026 07:00:00 GMTAstraZeneca/Daiichi’s Enhertu® (Trastuzumab Deruxtecan) + THP Approved in India for HER2-Positive Breast Cancer - Pearce IPPearce IP · Tue, 28 Jul 2026 07:00:00 GMTEMA Endorses New First-Line Roles For Enhertu, Trodelvy In Breast Cancer - insights.citeline.cominsights.citeline.com · Mon, 27 Jul 2026 07:00:00 GMT